PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.20%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-13.82%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-14.40%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-16.11%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-19.40%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-19.33%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-19.46%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.22%
Slight or no buybacks while ADI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.22%
Slight or no buyback while ADI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.05%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-47.14%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-129.77%
Negative FCF growth while ADI is at 28.83%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
45.79%
10Y revenue/share CAGR under 50% of ADI's 151.94%. Michael Burry would suspect a lasting competitive disadvantage.
5.11%
5Y revenue/share CAGR under 50% of ADI's 21.26%. Michael Burry would suspect a significant competitive gap or product weakness.
-13.52%
Negative 3Y CAGR while ADI stands at 20.07%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
161.49%
10Y OCF/share CAGR under 50% of ADI's 355.54%. Michael Burry would worry about a persistent underperformance in cash creation.
-5.20%
Negative 5Y OCF/share CAGR while ADI is at 127.82%. Joel Greenblatt would question the firm’s operational model or cost structure.
-44.30%
Negative 3Y OCF/share CAGR while ADI stands at 98.18%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
169.54%
Net income/share CAGR above 1.5x ADI's 91.02% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-6.31%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-36.13%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
89.97%
Below 50% of ADI's 366.92%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
105.71%
5Y equity/share CAGR at 75-90% of ADI's 128.19%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
69.26%
3Y equity/share CAGR at 50-75% of ADI's 119.01%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
332.40%
10Y dividend/share CAGR above 1.5x ADI's 153.14%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
68.60%
5Y dividend/share CAGR at 75-90% of ADI's 78.30%. Bill Ackman wants more robust earnings or a higher payout ratio to match the competitor.
27.51%
3Y dividend/share CAGR at 50-75% of ADI's 38.45%. Martin Whitman might see a weaker short-term approach to distributing cash.
-6.49%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.10%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
7.84%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.29%
1.25-1.5x ADI's 0.22%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
20.36%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
3.91%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
3.88%
SG&A growth well above ADI's 0.40%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.